GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
30 Oct 2019 12:07 PM
RNS
Second Price Monitoring Extn
30 Oct 2019 12:02 PM
RNS
Price Monitoring Extension
30 Oct 2019 12:00 PM
RNS
3rd Quarter Results
21 Oct 2019 08:00 AM
RNS
GSK divests two travel vaccines to Bavarian Nordic
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
15 Oct 2019 05:00 PM
RNS
Director/PDMR Shareholding
11 Oct 2019 05:34 PM
RNS
Director/PDMR Shareholding
11 Oct 2019 04:10 PM
RNS
Director/PDMR Shareholding
10 Oct 2019 04:18 PM
RNS
Director/PDMR Shareholding
01 Oct 2019 06:18 PM
RNS
Director/PDMR Shareholding
01 Oct 2019 01:09 PM
RNS
Total Voting Rights
30 Sep 2019 07:00 AM
RNS
Data show anti-tumour activity with ICOS agonist
30 Sep 2019 07:00 AM
RNS
PRIMA shows Zejula improves PFS in ovarian cancer
26 Sep 2019 06:26 PM
RNS
Director/PDMR Shareholding
17 Sep 2019 05:46 PM
RNS
Director/PDMR Shareholding
11 Sep 2019 04:30 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 05:37 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 12:36 PM
RNS
Director/PDMR Shareholding
04 Sep 2019 09:33 AM
RNS
Director/PDMR Shareholding
02 Sep 2019 11:29 AM
RNS
Total Voting Rights
23 Aug 2019 07:00 AM
RNS
GSK - positive results from pivotal DREAMM-2 study
22 Aug 2019 07:00 AM
RNS
ViiV results positive for every 2 month injection
21 Aug 2019 08:00 AM
RNS
GSK submits regulatory file in Japan: Daprodustat
12 Aug 2019 03:45 PM
RNS
Director/PDMR Shareholding
01 Aug 2019 03:30 PM
RNS
EU approval for Nucala self-administration
01 Aug 2019 02:10 PM
RNS
Total Voting Rights
01 Aug 2019 07:00 AM
RNS
GSK completes transaction with Pfizer for New JV
30 Jul 2019 03:35 PM
RNS
Director/PDMR Shareholding
29 Jul 2019 07:00 AM
RNS
ViiV submits cabotegravir to EMA for HIV injection
24 Jul 2019 06:01 PM
RNS
Director/PDMR Shareholding
24 Jul 2019 04:01 PM
RNS
ViiV 2DR TANGO switch study positive at 48 weeks
24 Jul 2019 04:00 PM
RNS
ViiV GEMINI studies show high efficacy at 96 weeks
24 Jul 2019 12:07 PM
RNS
Second Price Monitoring Extn
24 Jul 2019 12:02 PM
RNS
Price Monitoring Extension
24 Jul 2019 12:00 PM
RNS
2nd Quarter Results
24 Jul 2019 10:00 AM
RNS
Non-Executive Chairman
22 Jul 2019 05:00 PM
RNS
ViiV presents 96-week data from phase III study
15 Jul 2019 06:19 PM
RNS
Director/PDMR Shareholding
15 Jul 2019 06:18 PM
RNS
Director/PDMR Shareholding
15 Jul 2019 06:16 PM
RNS
Director/PDMR Shareholding
15 Jul 2019 11:42 AM
RNS
Director/PDMR Shareholding
15 Jul 2019 07:00 AM
RNS
positive results in Phase 3 PRIMA study of ZEJULA
12 Jul 2019 04:35 PM
RNS
Director/PDMR Shareholding
12 Jul 2019 03:55 PM
RNS
Director/PDMR Shareholding
10 Jul 2019 03:48 PM
RNS
Director/PDMR Shareholding
10 Jul 2019 07:00 AM
RNS
ViiV switch study shows 2DR as effective as 3DR
03 Jul 2019 09:00 AM
RNS
ViiV receives Dovato EU Marketing Authorisation
01 Jul 2019 12:08 PM
RNS
Total Voting Rights

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

GSK share price launched at 346p in 1989. 

UK 100

Latest directors dealings